Troy Lister
Verve Therapeutics (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Synthetic Organic Chemistry Methods, Antibiotics Pharmacokinetics and Efficacy, Microbial Natural Products and Biosynthesis, Marine Sponges and Natural Products
Most-Cited Works
- → New natural products as new leads for antibacterial drug discovery(2013)185 cited
- → Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741(2017)149 cited
- → Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection(2012)116 cited
- → Design, Synthesis, and Biological Evaluation of Platensimycin Analogues with Varying Degrees of Molecular Complexity(2008)113 cited
- → Adamantaplatensimycin: A Bioactive Analogue of Platensimycin(2007)111 cited
- → Treatment of Gram-negative bacterial infections by potentiation of antibiotics(2016)106 cited
- → Potentiation of Antibiotics against Gram-Negative Bacteria by Polymyxin B Analogue SPR741 from Unique Perturbation of the Outer Membrane(2019)104 cited
- → SPR741, an Antibiotic Adjuvant, Potentiates theIn VitroandIn VivoActivity of Rifampin against Clinically Relevant Extensively Drug-Resistant Acinetobacter baumannii(2017)74 cited
- → Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects(2019)53 cited
- → Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206(2021)45 cited